Sun Pharmaceutical Industries Ltd
- All
- News
- Videos
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
- Tuesday April 27, 2021
- India News | Reuters
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
www.ndtv.com
-
Sun Pharmaceutical Wins US Approval to Buy Ranbaxy
- Saturday January 31, 2015
- World News | Reuters
India's Sun Pharmaceutical Industries Ltd has won US approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the US Federal Trade Commission (FTC) said on Friday.
-
www.ndtv.com
-
Andhra Pradesh High Court Lifts Stay on Sun Pharma's $3.2 Billion Ranbaxy Takeover
- Sunday May 25, 2014
- India News | Reuters
The Andhra Pradesh High Court on Saturday lifted a temporary stay it imposed on generic drugmaker Sun Pharmaceutical Industries Ltd's $3.2 billion takeover of Ranbaxy Laboratories Ltd, a lawyer involved in the case said, paving the way for both companies to complete the deal.
-
www.ndtv.com
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
- Tuesday April 27, 2021
- India News | Reuters
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
www.ndtv.com
-
Sun Pharmaceutical Wins US Approval to Buy Ranbaxy
- Saturday January 31, 2015
- World News | Reuters
India's Sun Pharmaceutical Industries Ltd has won US approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the US Federal Trade Commission (FTC) said on Friday.
-
www.ndtv.com
-
Andhra Pradesh High Court Lifts Stay on Sun Pharma's $3.2 Billion Ranbaxy Takeover
- Sunday May 25, 2014
- India News | Reuters
The Andhra Pradesh High Court on Saturday lifted a temporary stay it imposed on generic drugmaker Sun Pharmaceutical Industries Ltd's $3.2 billion takeover of Ranbaxy Laboratories Ltd, a lawyer involved in the case said, paving the way for both companies to complete the deal.
-
www.ndtv.com